Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Oral Isotretinoin vs. Oral Tetracyclines for Moderate Acne Vulgaris
NCT06225570Phase 1Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of isotretinoin in acne vulgaris (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Comprehensive Acne Severity Scale at 10 months. Started Feb 2025; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06225570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225570.